David E. Davies

The discovery of GSK221149A: A potent and selective oxytocin antagonist

John Liddle, Michael Allen, Alan D. Borthwick et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

The cycloaddition of α-nitrosostyrenes to olefins. Investigations of the scope and mechanism of the reaction

David E. Davies, T. L. Gilchrist, Tony G. Roberts · Journal of the Chemical Society Perkin Transactions 1 · 1983 · 49 citations

Natural Sciences, Chemistry, Organic Chemistry +9

A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects

Martin Brunner, David E. Davies, Wolfgang Martin et al. · British Journal of Clinical Pharmacology · 2011 · 38 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Competing [4 + 2] and [3 + 2] cycloaddition in the reactions of nucleophilic olefins with ethyl 3-(toluene-p-sulphonylazo)but-2-enoate

Simon J. Clarke, David E. Davies, T. L. Gilchrist · Journal of the Chemical Society Perkin Transactions 1 · 1983 · 32 citations

Natural Sciences, Chemistry, Green Chemistry +12

Novel renin inhibitors: synthesis of aminostatine and comparison with statine-containing analogues

Richard J. Arrowsmith, Keith D. Carter, John G. Dann et al. · Journal of the Chemical Society Chemical Communications · 1986 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11